openPR Logo
Press release

Erythropoietin Drugs Market Top Players are Amgen Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals

01-30-2020 06:20 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Erythropoietin Drugs Market

Erythropoietin Drugs Market

"Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020", forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/59

Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% of the patients suffering from Cancer/HIV and ~70% of the patients suffering from ESRD undergo chemotherapy, which induces anemia in such patients, requiring EPO treatment. Despite this, the market nevertheless witnesses restraints due to highly priced EPO drugs resulting in minimal adoption. However, commercialization of EPO biosimilars would eventually ease the influence of restraints and fuel the market growth, primarily across the developing regions.

Globally, ~70% of the market share is held by the developed regions owing to favorable reimbursements leading to affordability for EPO drugs. Going forward, owing to commercialization of EPO biosimilars, the Asia-Pacific EPO drugs market would be the most potential market among other regions.

Key findings of the study:

Europe led the global EPO drug market in 2013 closely followed by North America
Asia Pacific EPO drugs market is projected to grow at a CAGR of 13.3% during the forecast period, fastest among the four geographies
Currently, Anemia therapeutics (Cancer and HIV treatment) market leads the overall EPO drugs market; however, kidney therapeutic segment would emerge as the largest market segment by 2020
Originator companies are investing in R&D for expanding product i.e. EPO drug applications to newer disorders such as neural diseases and in wound healing
EPO drugs market is witnessing high commercialization of biosimilars for the 'off-patent' drug namely Erythropoietin alfa

To view the report, visit the website at http://www.alliedmarketresearch.com/erythropoietin-market

The first EPO drug - Epogen (Erythropoietin alfa), launched by Amgen, has witnessed patent expiry in 2014. Following this, a number of biosimilar Erythropoietin alfa have been launched by major companies such as Biocon, Ranbaxy, Emcure Pharmaceuticals. In addition, Amgen currently owns the patent Aranesp for Darbepoetin alfa; which is expected to expire by 2016, thus, calling for launch of Darbepoetin alfa biosimilars.

Some of leading players operating in EPO drug market are Amgen Inc., Johnson & Johnson, Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.

Related Reports:
Nephrology and Urology Devices Market
https://www.alliedmarketresearch.com/nephrology-urology-devices-market

Human Insulin Market
https://www.alliedmarketresearch.com/human-insulin-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erythropoietin Drugs Market Top Players are Amgen Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals here

News-ID: 1914737 • Views: โ€ฆ

More Releases from Allied Market Research

Nanosatellite and Microsatellite Market Share Reach USD 8.69 Billion by 2030
Nanosatellite and Microsatellite Market Share Reach USD 8.69 Billion by 2030
๐๐š๐ง๐จ๐ฌ๐š๐ญ๐ž๐ฅ๐ฅ๐ข๐ญ๐ž ๐š๐ง๐ ๐Œ๐ข๐œ๐ซ๐จ๐ฌ๐š๐ญ๐ž๐ฅ๐ฅ๐ข๐ญ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ by End User (Civil, Government, Commercial, and Military), Application (Communications, Earth Observation, Space Science, Technology Demonstration, and Technology Development), and Orbit Type (Non-Polar Inclined, Polar, and Sun-Synchronous): Global Opportunity Analysis and Industry Forecast, 2021-2030." As per the report, the global nanosatellite and microsatellite industry was accounted for $2.23 billion in 2020, and is expected to reach $8.69 billion by 2030, growing at a CAGR of 14.9%โ€ฆ
Anti-Drone Market is experiencing significant growth and is anticipated to attain a CAGR of 27.9% by the year 2031
Anti-Drone Market is experiencing significant growth and is anticipated to attai โ€ฆ
๐€๐ง๐ญ๐ข-๐ƒ๐ซ๐จ๐ง๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ by Technology (Electronic System, Laser System, Kinetic System), by Application (Detection, Disruption), by End Use (Government, Military & Defense, Commercial), by Platform (Ground, Handheld, UAV Based): Global Opportunity Analysis and Industry Forecast, 2021- 2031". According to the report, the global anti-drone industry generated $1.3 billion in 2021 and is anticipated to generate $14.6 billion by 2031, witnessing a CAGR of 27.9% from 2022 to 2031. ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐๐จ๐ฐ:โ€ฆ
Home Exercise Bike Market is expected to witness robust Compound Annual Growth Rate (CAGR) progress of 8.7% from 2021 to 2027.
Home Exercise Bike Market is expected to witness robust Compound Annual Growth R โ€ฆ
According to a new report published by Allied Market Research, titled, "Home Exercise Bike Market by Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," The global home exercise bike market size was valued at $1,213.5 million in 2019, and is projected to reach $2,335.2 million by 2027, registering a CAGR of 8.7% from 2021 to 2027. The recumbent segment is expected to retain its dominant position, in termsโ€ฆ
Rapidly expanding entertainment products industry is set to drive the growth of the $103.8 billion Toys market ; Ravensburger AG, Tomy Company, Ltd, Vtech Holdings, and Thames & Kosmos.
Rapidly expanding entertainment products industry is set to drive the growth of โ€ฆ
According to a new report published by Allied Market Research, titled, "Toys Market by Product Type, Age Group and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," the toys market size was $92.2 billion in 2019, and is projected reach $103.8 billion by 2027, registering a CAGR of 2.5% from 2021 to 2027. The increase in number of games bars, cafes and family entertainment centers worldwide is boosting the demand forโ€ฆ

All 5 Releases


More Releases for EPO

Global EPO Biomarkers Market Share: Trends, Key Players, Industry Analysis Repor โ€ฆ
The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfaโ€ฆ
EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 20 โ€ฆ
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancerโ€ฆ
EPO Biomarkers Market : Industry Research, Study, Growth Analysis Report 2019 & โ€ฆ
Researchmoz added Most up-to-date research on โ€œGlobal EPO Biomarkers Market Size, Status and Forecast 2019-2025โ€ to its huge collection of research reports. The EPO Biomarkers market report [6 Year Forecast 2019-2025] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis isโ€ฆ
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,โ€ฆ
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered toโ€ฆ
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin โ€ฆ
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced inโ€ฆ